Inhibition of BAD phosphorylation either at serine 112 via extracellular signal-regulated protein kinase cascade or at serine 136 via Akt cascade sensitizes human ovarian cancer cells to cisplatin.

Jun Hayakawa(The University of Osaka), Yuji Murata(The University of Osaka), Koji Hisamoto(Osaka Police Hospital), Yuki Kanda(Kindai University), Kazushige Adachi, Yukihiro Nishio, Hirohisa Kurachi(Osaka Women's and Children's Hospital), Toru Kanzaki(Yamagata University Hospital), Masahide Ohmichi(Osaka University of Pharmaceutical Sciences), Keiichi Tasaka(Eunice Kennedy Shriver National Institute of Child Health and Human Development)
PubMed
November 1, 2000
Cited by 249


Related Papers